Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00277-022-04976-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CALR loss-of-heterozygosity as a potential driver for extramedullary AML.
Ann Hematol
November 2022
Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis.
Int J Hematol
September 2020
Escola de Saude e Medicina da Universidade Catolica de Brasilia, Brasilia, Brazil.
Genomic characterization of patients with myeloproliferative neoplasms (MPN) may lead to better diagnostic classification, prognostic assessment, and treatment decisions. These goals are particularly important in myelofibrosis (MF). We performed target Next Generation Sequencing for a panel of 255 genes and Chromosome Microarray Analysis (CMA) in 27 patients with MF.
View Article and Find Full Text PDF[Essential thrombocythemia correctly diagnosed through the guidance of comprehensive genomic profiling].
Rinsho Ketsueki
January 2020
Department of Hematology, Tazuke Kofukai, Medical Research Institute, Kitano Hospital.
In 2003, a 60-year-old man presenting with thrombocytosis was referred to our hospital. Laboratory tests revealed normal white blood cell count and hemoglobin level. Bone marrow examination showed an increased number of megakaryocytes with dysplasia.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!